Navigation Links
SulphCo Adds New Board Member
Date:8/28/2008

HOUSTON, Aug. 28 /PRNewswire-FirstCall/ -- SulphCo, Inc. (the "Company" or "SulphCo") (Amex: SUF), a technology company with a patented ultrasound process to desulfurize crude oil, announced today the appointment of Fred S. Zeidman to the Company's Board of Directors.

"We are pleased to have Mr. Zeidman join SulphCo's Board of Directors," said Dr. Larry D. Ryan, Chief Executive Officer of SulphCo. "The Company will benefit from his extensive experience, both in the executive suite and the boardroom, along with his solid understanding of the energy business. I believe Mr. Zeidman will be a valuable asset in our future growth and development."

Mr. Zeidman has held leadership positions in a number of energy related companies. He is the former Chairman of the Board of Houston-based Seitel, Inc., a leading provider of seismic data and related geophysical expertise to the petroleum industry. He also served as Chairman of the Board of Unibar Corporation, the largest domestic independent drilling fluids company, until its sale in 1991 to Anchor Drilling Fluids. He currently serves as Interim President for Nova Biosource Fuels, Inc. (Amex), a refiner and marketer of renewable biodiesel fuel products. Mr. Zeidman is also a Senior Director for Governmental Affairs at Greenberg, Traurig's Washington D.C. law office.

"Having spent most of my career in the energy sector, I understand the value proposition of SulphCo's economical ultrasound solution to the complex and expensive problem of sulphur removal," said Zeidman. "I am excited to join the SulphCo Board and look forward to the opportunity to contribute to the success of this revolutionary technology as it transitions into the commercial phase."

An active participant in community, political and non-profit organizations, Mr. Zeidman currently serves as Chairman of the Holocaust Museum in Washington D.C. and Vice Chairman of the McCain for President Campaign. He also holds leadership roles in numerous non-profit organizations serving the arts, health care, academia and the Jewish community.

Mr. Zeidman is a graduate of Washington University and received an MBA from New York University. He currently lives in Houston with his wife and children.

About SulphCo, Inc.

The Company has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The Company's technology is designed to upgrade sour heavy crude oils into sweeter, lighter crude oils, producing more gallons of usable oil per barrel.

From time to time, the Company may issue forward-looking statements, which involve risks and uncertainties. This statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as actual results could differ and any forward-looking statements should be considered accordingly.


'/>"/>
SOURCE SulphCo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
2. GM Exec Joins Bio-Reaction Industries Board of Directors
3. Regenesis Biomedical Announces Additions to Board of Directors
4. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
7. Omeros Appoints David A. Mann to its Board of Directors
8. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
9. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
10. ThermoGenesis Names Tiffany Olson to Board of Directors
11. SpineMark Appoints Dr. Rudolf Bertagnoli Chairman of International Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, Jake Lubinski, describes ... characteristics when deformed, which is identical to how the human discs work to ... and return to its natural state along a hysteresis curve, exactly like a ...
(Date:3/23/2017)... -- GlobeImmune, Inc. today announced it has entered into a ... of its common stock to NantCell, Inc., a member ... sale of its common stock, NantCell has agreed to ... 200,000 shares, an estimated $2.0 million in value, of ... to enter into this strategic agreement with NantCell," said ...
(Date:3/23/2017)... York , March 23, 2017 According ... plasma products and derivatives market is fragmented due to the presence of ... such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with ... these three companies, collectively, held more than 76% of this market ... As ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a ... lab samples to full-size tissues, bones, even whole organs to implant in people ... delivers blood deep into the developing tissue. , Current bioengineering techniques, including ...
Breaking Biology Technology:
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
Breaking Biology News(10 mins):